Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models
Abstract We previously developed human CAR macrophages (CAR-M) and demonstrated redirection of macrophage anti-tumor function leading to tumor control in immunodeficient xenograft models. Here, we develop clinically relevant fully immunocompetent syngeneic models to evaluate the potential for CAR-M...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Nature Portfolio
2025-01-01
|
| Seria: | Nature Communications |
| Dostęp online: | https://doi.org/10.1038/s41467-024-55770-1 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
